Mr. Nixon brings over 25 years of life sciences investing and operating experience to BioAesthetics. He currently serves as Chief Financial Officer for Locus Biosciences, a biopharmaceutical company that is developing innovative antibacterial products, where he led financing and partnering transactions with total potential value at signing of nearly $1 billion. Before joining Locus in 2017, Mr. Nixon led the investment team at the North Carolina Biotechnology Center where he led or supervised investments in more than 60 early-stage life science companies. He previously held business development and licensing positions with Novartis and Alkermes, was Product Manager for a venture-backed bioinformatics start-up company, and helped launch start-up companies at the Cleveland Clinic. Mr. Nixon earned a B.S. in Biology from Case Western Reserve University and an M.B.A. from Harvard Business School.